| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3862559 | The Journal of Urology | 2013 | 4 Pages |
Abstract
Off-label use of polyacrylamide hydrogel injection therapy for primarily low grade vesicoureteral reflux demonstrates that the technique and short-term success rates are comparable to the most popular bulking agent, dextranomer/hyaluronic acid. These results suggest that further trials comparing polyacrylamide hydrogel and dextranomer/hyaluronic acid would be worthwhile.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jonathan Cloutier, Anne-Sophie Blais, Katherine Moore, Stéphane Bolduc,